Business Description
Biomaxima SA
ISIN : PLBIOMX00015
Description
Biomaxima SA is a Polish company, produces microbiology media as well as a wide range of reagents and in Vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics companies such as Nova Biomedical, Mitsubishi Chemical and Biologist. Its products include Systems Antibiotic Susceptibility Testing, Urine Analysis Systems, Hematological Reagents along with Analyzers, ion Selective Analyzers with Reagents, Immunological Analyzer of Cardiac markers with reagents, Glucose Meters and analyzers for Gasometric and Critical Blood Tests.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.16 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | 2.43 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.15 | |||||
| Beneish M-Score | -1.95 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 58 | |||||
| 3-Year EBITDA Growth Rate | 140.2 | |||||
| 3-Year EPS without NRI Growth Rate | 673.3 | |||||
| 3-Year FCF Growth Rate | 90.5 | |||||
| 3-Year Book Growth Rate | 42.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.93 | |||||
| 9-Day RSI | 35.23 | |||||
| 14-Day RSI | 39.32 | |||||
| 6-1 Month Momentum % | -8.62 | |||||
| 12-1 Month Momentum % | -41.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.24 | |||||
| Quick Ratio | 0.85 | |||||
| Cash Ratio | 0.15 | |||||
| Days Inventory | 176.11 | |||||
| Days Sales Outstanding | 67.88 | |||||
| Days Payable | 54.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.66 | |||||
| Dividend Payout Ratio | 3.16 | |||||
| Forward Dividend Yield % | 3.66 | |||||
| 5-Year Yield-on-Cost % | 3.79 | |||||
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | 9.55 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 40.64 | |||||
| Operating Margin % | -0.47 | |||||
| Net Margin % | 1.72 | |||||
| FCF Margin % | -39.27 | |||||
| ROE % | 1.54 | |||||
| ROA % | 1.1 | |||||
| ROIC % | -0.33 | |||||
| ROC (Joel Greenblatt) % | 2.64 | |||||
| ROCE % | 2.32 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 74.9 | |||||
| PE Ratio without NRI | 85.33 | |||||
| Shiller PE Ratio | 9.68 | |||||
| PEG Ratio | 1.08 | |||||
| PS Ratio | 1.25 | |||||
| PB Ratio | 1.11 | |||||
| Price-to-Tangible-Book | 1.13 | |||||
| Price-to-Operating-Cash-Flow | 34.94 | |||||
| EV-to-EBIT | 46.55 | |||||
| EV-to-EBITDA | 18.25 | |||||
| EV-to-Revenue | 1.46 | |||||
| EV-to-FCF | -3.68 | |||||
| Price-to-Projected-FCF | 1.41 | |||||
| Price-to-Median-PS-Value | 1.9 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.46 | |||||
| Price-to-Graham-Number | 2.08 | |||||
| Earnings Yield (Greenblatt) % | 2.15 | |||||
| FCF Yield % | -32.13 | |||||
| Forward Rate of Return (Yacktman) % | 20.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biomaxima SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil zł) | 46.819 | ||
| EPS (TTM) (zł) | 0.18 | ||
| Beta | 0.36 | ||
| Volatility % | 34.48 | ||
| 14-Day RSI | 39.32 | ||
| 14-Day ATR (zł) | 0.568515 | ||
| 20-Day SMA (zł) | 14.86 | ||
| 12-1 Month Momentum % | -41.95 | ||
| 52-Week Range (zł) | 12.16 - 25.6 | ||
| Shares Outstanding (Mil) | 4.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biomaxima SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biomaxima SA Stock Events
| Event | Date | Price(zł) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biomaxima SA Frequently Asked Questions
What is Biomaxima SA(WAR:BMX)'s stock price today?
The current price of WAR:BMX is zł13.65. The 52 week high of WAR:BMX is zł25.60 and 52 week low is zł12.16.
When is next earnings date of Biomaxima SA(WAR:BMX)?
The next earnings date of Biomaxima SA(WAR:BMX) is .
Does Biomaxima SA(WAR:BMX) pay dividends? If so, how much?
The Dividend Yield %  of Biomaxima SA(WAR:BMX) is 3.66% (As of Today), Highest Dividend Payout Ratio of Biomaxima SA(WAR:BMX) was 3.16. The lowest was 0.07. And the median was 0.21. The  Forward Dividend Yield % of Biomaxima SA(WAR:BMX) is 3.66%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers